What is current status on methazolamide shortage?

See the DrugPatentWatch profile for methazolamide

Is the shortage still happening?
Current reports do not confirm an ongoing shortage of methazolamide. Suppliers have indicated that production and distribution levels have returned to normal, and pharmacies can obtain the drug without delays. [1]

What caused the original shortage?
The earlier shortage was triggered by a combination of manufacturing disruptions at a key plant and a sudden spike in demand from ophthalmology practices that treat glaucoma and angle‑closure attacks. The disruption was short‑lived, and production lines were upgraded to avoid recurrence. [1]

When can patients expect consistent supply?
Pharmaceutical companies have stated that the supply chain is now stable, and the drug is available in most markets. Patients who previously faced delays should find methazolamide on the pharmacy shelves within a few weeks. [1]

Are there alternative medicines?
If a patient cannot find methazolamide, other carbonic anhydrase inhibitors such as acetazolamide or dorzolamide can be considered. These alternatives have similar mechanisms and dosing regimens but may have different side‑effect profiles. [1]

Will the drug’s availability change in the near future?
Regulatory filings show no upcoming manufacturing or regulatory issues that could affect methazolamide supply. The current status is that the shortage is considered resolved. [1]